Heyu Ni, MD, PhD
Department of Laboratory Medicine and Pathobiology
Department of Medicine, and Department of Physiology
University of Toronto, Toronto, Canada
Dr. Ni received his M.D. (eqv.) and M.Sc. in Microbiology and Immunology from Anhui Medical University, China, where he also completed his intern residency. He received his PhD in Immunology from the University of Manitoba, Canada, and postdoctoral training in Department of Pathology from Harvard Medical School, USA. He is a Scientist of the Canadian Blood Services Centre for Innovation, the Platform Director for Hematology, Cancer and Immunological Diseases at St. Michael's Hospital, and the Founder/President of CCOA therapeutic Inc. He has been a full professor in the Department of Laboratory Medicine and Pathobiology, Department of Medicine, and Department of Physiology at the University of Toronto since 2013.
Dr. Ni’s laboratory currently investigates the roles of adhesion molecules involved in thrombosis/hemostasis, inflammation/immune response, and tumorigenesis. His team is studying the mechanisms of these processes using a confocal intravital microscopy suite, proteomics, and gene targeted mice. By directly monitoring molecular/cellular events in vivo, they hope to uncover some novel mechanisms of platelet aggregation, platelet-leukocyte/cancer cell interactions to enrich our knowledge in heart attack and stroke, inflammation, and tumor metastasis. The laboratory also studies allo- and autoimmune diseases related to bleeding disorders such as Immune Thrombocytopenia (ITP), Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT). His studies have been well funded by both internal and external grant agencies including Canadian Institutes of Health Research (CIHR), Heart and Stroke Foundation of Canada (HSFC), Canadian Blood Services (CBS), Canadian Foundation for Innovation (CFI), National Institutes of Health (NIH, USA), and NSFC-CIHR (China-Canada Joint Health Research Initiative Program). Dr. Ni has > 110 scientific publications, many of them are published in high impact journals. He is a reviewer for more than 20 scientific journals, sits on various scientific committees and granting agencies in Canada, USA, China, and Europe and lectures at the local, national and international level.